NasdaqGS:ADPTLife Sciences
Assessing Adaptive Biotechnologies (ADPT) Valuation After Recent Share Price Weakness
Recent performance snapshot for Adaptive Biotechnologies (ADPT)
Adaptive Biotechnologies (ADPT) has drawn investor attention after a mixed performance, with the share price roughly flat over the past month but showing a 25% decline over the past 3 months.
See our latest analysis for Adaptive Biotechnologies.
At the current share price of $13.82, Adaptive Biotechnologies shows a 25.5% 3 month share price decline, while the 1 year total shareholder return of 75.2% points to stronger longer term...